Home Featured Page 210

Featured

Latest

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human Psyche

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples Therapy

Taking the Helm at Helus: A Brief Q&A With New CEO Michael Cola

The Psychedelic Practitioner Issue 3: Dosing

Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study...

PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid...

Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human...

Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments

MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test

Small Pharma Strengthens Board With Appointment of Paul Maier as Independent...

Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for...

Eyes on Oregon, a Psychedelics Today Podcast with Jon Dennis and...

Filament Health Announces Co-Development and Exclusive Licensing Agreement with Entheotech Bioscience

Psychedelic Bypassing: When Avoidance is Mistaken for Healing

1...209210211...308 Page 210 of 308

EDITOR PICKS

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human...

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human Psyche

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples Therapy

Taking the Helm at Helus: A Brief Q&A With New CEO Michael Cola

The Psychedelic Practitioner Issue 3: Dosing

Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study...

PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid...

Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human...

Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments

MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test

Small Pharma Strengthens Board With Appointment of Paul Maier as Independent...

Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for...

Eyes on Oregon, a Psychedelics Today Podcast with Jon Dennis and...

Filament Health Announces Co-Development and Exclusive Licensing Agreement with Entheotech Bioscience

Psychedelic Bypassing: When Avoidance is Mistaken for Healing

EDITOR PICKS

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human...

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY